Tirzepatide 20mg

Entry-Level Dual GIP/GLP-1 Agonist for Focused Research

Tirzepatide 20mg is an accessible entry-level dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for focused metabolic research. This 20mg supply provides researchers with an economical option to explore groundbreaking dual incretin mechanisms without overcommitting resources.

Why Researchers Choose Tirzepatide 20mg:

• Accessible Entry Point: 20mg provides an economical way to begin tirzepatide research
• Budget-Friendly: Most cost-effective option for laboratories with limited research budgets
• Dual Mechanism Innovation: Access to first-in-class dual GIP/GLP-1 receptor agonist technology
• Focused Research: Ideal quantity for specific experiments and proof-of-concept studies
• No Waste: Perfect amount for targeted investigations without excess material
• Same High Quality: Pharmaceutical-grade purity (≥98%) as larger formats
• Quick Start: Begin research immediately with this ready-to-use quantity
• Protocol Development: Perfect for optimizing experimental protocols before scaling up

Ideal Research Applications:

Perfect for laboratories initiating tirzepatide research, conducting preliminary studies, or working with specific research objectives. Tirzepatide 20mg is particularly valuable for researchers who:

• Are new to dual incretin receptor agonist research
• Need to validate experimental protocols and methodologies
• Want to explore tirzepatide's mechanisms before larger investments
• Are conducting focused, hypothesis-driven experiments
• Have specific research questions requiring limited material
• Are comparing tirzepatide with other metabolic peptides
• Need to demonstrate feasibility for grant applications
• Are working within tight budget constraints

Key Research Areas:

• Dual incretin receptor activation mechanisms
• Body weight regulation and appetite control
• Glucose-dependent insulin secretion pathways
• Satiety signaling and food intake regulation
• Metabolic rate and energy expenditure
• Beta-cell function and glucose homeostasis
• Lipid metabolism and fat distribution
• Comparative efficacy with single-receptor agonists
• Dose-response relationship studies

Technical Specifications:

• Quantity: 20mg (focused research supply)
• Type: Dual GIP/GLP-1 receptor agonist
• Structure: 39 amino acid synthetic peptide
• Form: Lyophilized powder for reconstitution
• Purity: ≥98% (HPLC verified)
• Molecular Weight: ~4813 Da
• Storage: Store at 2-8°C before reconstitution; -20°C after reconstitution
• Solubility: Reconstitute with bacteriostatic water
• Stability: Enhanced stability profile with C20 fatty acid modification
• Quality: Pharmaceutical-grade for reliable results

Research Advantages:

Tirzepatide represents a paradigm shift in incretin-based research, combining GIP and GLP-1 receptor activation to produce superior metabolic outcomes. The 20mg supply provides researchers with an accessible entry point to this groundbreaking peptide technology.

Unique Mechanism: Unlike single-receptor agonists, Tirzepatide activates both GIP and GLP-1 receptors simultaneously, leading to enhanced insulin secretion, reduced glucagon levels, delayed gastric emptying, and significant appetite suppression. This dual activation creates synergistic effects that surpass individual receptor stimulation.

Clinical Breakthrough: Tirzepatide has demonstrated unprecedented efficacy in clinical trials, with weight loss results exceeding 20% and superior glycemic control compared to existing treatments. This makes it a critical tool for understanding next-generation metabolic therapeutics.

Perfect for Initial Studies: The 20mg quantity is ideal for researchers who want to explore tirzepatide's unique mechanisms and validate their experimental approaches before committing to larger research programs. It provides sufficient material for initial experiments and protocol optimization.

Cost-Effective Exploration: For laboratories new to tirzepatide research or working with limited budgets, the 20mg format offers an accessible entry point while maintaining the same pharmaceutical-grade quality as larger quantities.

Proof-of-Concept Studies: This quantity is perfect for generating preliminary data for grant applications, demonstrating feasibility of research approaches, and validating hypotheses before scaling up to more extensive investigations.

Research Efficiency: With 20mg, researchers can conduct focused experiments, test specific hypotheses, and gather meaningful data without the financial commitment of larger quantities. This allows for strategic research planning and resource allocation.

Quality Assurance: Each batch undergoes rigorous HPLC testing to ensure ≥98% purity, providing you with the confidence needed for reliable results and reproducible findings, regardless of quantity purchased.

Important Disclaimer: This product is sold exclusively for research and laboratory purposes. Not intended for human consumption, therapeutic use, weight loss applications, or veterinary use. For in vitro and animal research only.

*Price per vial.
*This product is in powder form and is not reconstituted.
*For research purposes only.
*Tested at 99% purity.
*Free shipping.
*All sales final.